Detalhe da pesquisa
1.
CHOROIDAL THICKNESS IN MULTISYSTEMIC AUTOIMMUNE DISEASES WITHOUT OPHTHALMOLOGIC MANIFESTATIONS.
Retina
; 37(3): 529-535, 2017 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-27429379
2.
Long-Term Effect of Anti-VEGF Agents on Intraocular Pressure in Age-Related Macular Degeneration.
Ophthalmic Res
; 56(1): 30-4, 2016.
Artigo
em Inglês
| MEDLINE | ID: mdl-27046391
3.
Switch to Aflibercept in the Treatment of Neovascular AMD: One-Year Results in Clinical Practice.
Ophthalmologica
; 233(3-4): 155-61, 2015.
Artigo
em Inglês
| MEDLINE | ID: mdl-25896317
4.
Switch from intravitreal ranibizumab to bevacizumab for the treatment of neovascular age-related macular degeneration: clinical comparison.
Ophthalmologica
; 232(3): 149-55, 2014.
Artigo
em Inglês
| MEDLINE | ID: mdl-25196907
5.
Early Longitudinal Spectral Domain Optical Coherence Tomography Findings in Subacute Sclerosing Panencephalitis.
Retina
; 37(5): e45-e47, 2017 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-28423386
6.
Ranibizumab treatment for choroidal neovascularization from causes other than age-related macular degeneration and pathological myopia.
Ophthalmologica
; 225(2): 81-8, 2011.
Artigo
em Inglês
| MEDLINE | ID: mdl-20881442
7.
Arterial thromboembolic events in patients with exudative age-related macular degeneration treated with intravitreal bevacizumab or ranibizumab.
Ophthalmologica
; 225(4): 211-21, 2011.
Artigo
em Inglês
| MEDLINE | ID: mdl-21336001
8.
Off-Label Use of 0.19 mg Fluocinolone Acetonide Intravitreal Implant: A Systematic Review.
J Ophthalmol
; 2021: 6678364, 2021.
Artigo
em Inglês
| MEDLINE | ID: mdl-34055398
9.
Intravitreal bevacizumab for neovascular age-related macular degeneration with or without prior treatment with photodynamic therapy: one-year results.
Retina
; 30(1): 85-92, 2010 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-20010320
10.
Treatment of Neovascular Age-Related Macular Degeneration with Anti-VEGF Agents: Predictive Factors of Long-Term Visual Outcomes.
J Ophthalmol
; 2017: 4263017, 2017.
Artigo
em Inglês
| MEDLINE | ID: mdl-28656102
11.
Switch to Aflibercept in the Treatment of Neovascular AMD: Long-Term Results.
J Ophthalmol
; 2017: 6835782, 2017.
Artigo
em Inglês
| MEDLINE | ID: mdl-29201458
12.
Treatment of neovascular age-related macular degeneration with anti-VEGF agents: retrospective analysis of 5-year outcomes.
Clin Ophthalmol
; 10: 541-6, 2016.
Artigo
em Inglês
| MEDLINE | ID: mdl-27099460
13.
Optical coherence tomography study of peripapillary retinal nerve fiber layer and choroidal thickness in eyes with tilted optic disc.
J Glaucoma
; 24(1): 45-50, 2015 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-23429636
14.
Open-globe injuries at an emergency department in Porto, Portugal: clinical features and prognostic factors.
Eur J Ophthalmol
; 24(6): 932-9, 2014.
Artigo
em Inglês
| MEDLINE | ID: mdl-24744111
15.
Choroidal and macular thickness changes induced by cataract surgery.
Clin Ophthalmol
; 8: 55-60, 2014.
Artigo
em Inglês
| MEDLINE | ID: mdl-24368877
16.
A clear cell renal cell carcinoma inhibiting the response to intravitreal antivascular endothelial growth factor therapy in wet age-related macular disease.
Case Rep Ophthalmol
; 3(3): 443-51, 2012 Sep.
Artigo
em Inglês
| MEDLINE | ID: mdl-23341823
17.
Comparative study of 1+PRN ranibizumab versus bevacizumab in the clinical setting.
Clin Ophthalmol
; 6: 1149-57, 2012.
Artigo
em Inglês
| MEDLINE | ID: mdl-22973087
18.
Vascular endothelial growth factor plasma levels before and after treatment of neovascular age-related macular degeneration with bevacizumab or ranibizumab.
Acta Ophthalmol
; 90(1): e25-30, 2012 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-21958440
19.
On capsule membrane fixation.
JAMA Ophthalmol
; 131(6): 821, 2013 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-23764713